Dr. Peter Vun Chen, MD

Dr. Chen practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Chen's NPI, 1720031800, was assigned on May 18, 2006. Dr. Chen graduated from David Geffen School of Medicine at UCLA in 1998. Dr. Chen holds California license A70756.

Dr. Chen's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Chen also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Chen's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. The medical group on file is Newport Coast Radiation Oncology Medical Group. Dmand AI also links Dr. Chen to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Chen is board certified in radiation oncology by the American Board of Radiology. Dr. Chen is licensed in California.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI and cervical cancer radiation among the conditions Dr. Chen treats.

CMS data shows 4,536 Medicare services from Dr. Chen across 19 procedure codes in 2024, for 362 Medicare patients. Medicare paid $339,814 for them.

CMS counts 362 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 70, with 54% women.

In 2024, Dr. Chen wrote 29 Medicare Part D claims for 24 patients. 93% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $412 in total drug cost. In 2020, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 18 papers to Dr. Chen, published from 2007 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Intraoperative Care, Breast Neoplasms and Mastectomy, Segmental. Dr. Chen has published most often in Ann Surg Oncol. Dr. Chen's most frequent co-authors are Melvin J. Silverstein, MD, Peter Chen, MD and Kevin Lin, MD.

Dmand AI links Dr. Chen to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 11 general payments to Dr. Chen from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Gilead Sciences, Inc. paid the most, $208.

Dr. Chen graduated from David Geffen School of Medicine at UCLA in 1998.

Dr. Chen is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.